DEEP-EXPRESS-ZERTIFIKATE - FRESENIUS MEDICAL CARE Stock

Certificat

DE000LB2H3A4

Real-time Boerse Frankfurt Warrants 09:15:09 2024-05-28 EDT
684.4 EUR -0.71% Intraday chart for DEEP-EXPRESS-ZERTIFIKATE - FRESENIUS MEDICAL CARE
Current month+4.09%
1 month+3.89%
Date Price Change
24-05-28 684.4 -0.71%
24-05-27 689.2 -1.26%
24-05-22 698.1 -0.85%
24-05-21 704 -1.30%
24-05-20 713.3 -0.47%

Real-time Boerse Frankfurt Warrants

Last update May 28, 2024 at 09:15 am

More quotes

Static data

Product typesonstige Zertifikate
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer LBBW
WKN LB2H3A
ISINDE000LB2H3A4
Date issued 2020-04-28
Strike 72
Maturity 2026-06-19 (752 Days)
Parity 0.07 : 1
Emission price 1,000
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 1,026
Lowest since issue 429.2
Spread 16.62
Spread %2.37%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
38.77 EUR
Average target price
39.84 EUR
Spread / Average Target
+2.77%
Consensus